Diverse Mouth Bacteria Tied to Lower Heart, Kidney and Death Risk

If you have ever wondered whether the health of your mouth says anything about the rest of your body, a new analysis of a large United States health survey suggests the answer is yes, and the connection runs deeper than gum disease. Researchers tracked over 6,000 adults for nearly nine years and found that the mix of bacteria living on their gums, tongue, and cheeks tracked with their risk of advanced cardiovascular-kidney-metabolic disease and, ultimately, how long they lived. The findings do not prove that a richer oral microbiome protects the heart, but they add oral bacteria to a growing list of biological signals worth paying attention to.

Key takeaways

• Adults with higher oral microbial diversity (a measure of how many different bacterial species live in the mouth, and how evenly they are distributed) had 9 to 30% lower odds of advanced cardiovascular-kidney-metabolic (CKM) syndrome.
• All four diversity measures tested predicted 15 to 43% lower all-cause mortality over a median of 8.83 years, and two of them predicted roughly 18 to 21% lower cardiovascular death.
• Frailty (a measure of accumulated age-related health deficits) statistically accounted for 15 to 37% of the mortality link, hinting at one possible pathway.
• This is an observational study: it cannot prove oral bacteria cause these outcomes, and diversity was measured only once per person.

Oral Microbial Diversity Predicts CKM Syndrome and Mortality Risk

Researchers analyzing data from the National Health and Nutrition Examination Survey (NHANES) found that adults with greater oral microbial alpha-diversity (a measure combining how many bacterial species are present and how evenly they are distributed, versus one or two species dominating) were less likely to have advanced cardiovascular-kidney-metabolic (CKM) syndrome and less likely to die during follow-up, according to a study published in the Journal of Oral Microbiology. The strongest single predictor, a metric called Faith's phylogenetic diversity (PD), which weighs how evolutionarily distinct the bacterial species in a sample are, was linked to 9% lower odds of advanced CKM for every one standard deviation increase, and people in the top quarter of diversity had 30% lower odds than those in the bottom quarter. All four diversity metrics the researchers tested, including two other measures called the Shannon-Weiner and Simpson indices, independently predicted lower all-cause mortality, with people in the highest diversity quartile facing 39 to 43% lower risk of death from any cause than those in the lowest quartile.

Why Cardiovascular-Kidney-Metabolic Syndrome Patients Should Take Notice

CKM syndrome is the American Heart Association's newer framework, introduced in an October 2023 presidential advisory, for describing how obesity, type 2 diabetes, chronic kidney disease, and cardiovascular disease feed into each other rather than existing as separate conditions. More than a quarter of US adults are estimated to meet criteria for some stage of CKM syndrome, and it already accounts for over three-quarters of cardiometabolic-related healthcare spending in the country. For someone already managing prediabetes, high blood pressure, reduced kidney function, or an existing heart condition, that means this study's population overlaps heavily with people actively trying to understand and manage their own cardiometabolic risk. The study specifically looked at "advanced" CKM, meaning stage 3 or 4 on the AHA's five-stage scale, which covers people who already have subclinical or clinical cardiovascular disease layered on top of metabolic or kidney dysfunction, so the oral microbiome findings speak most directly to that higher-risk group.

How the NHANES Cohort Study Was Designed

The team drew on two consecutive NHANES survey cycles that sequenced oral rinse samples, 2009-2010 and 2011-2012, since these are the only cycles in which the government survey performed this kind of microbiome sequencing. After excluding participants younger than 30, those without oral microbiome data, pregnant women, and people with incomplete CKM staging information, 6,044 adults with a mean age of 48.9 remained for the CKM analysis. Participants rinsed with mouthwash to collect a sample, which was then processed using 16S rRNA gene sequencing (a standard genetic technique for identifying which bacterial species are present in a sample without fully sequencing every microbial gene). Mortality was tracked through the end of 2019 via national death records, during which time researchers recorded 402 deaths from any cause, 144 of them from cardiovascular disease, over a median follow-up of 8.83 years. The researchers adjusted their statistical models for age, sex, race and ethnicity, education, income, smoking, alcohol use, marital status, and gum disease (periodontitis), and the associations held up across four separate sensitivity analyses designed to rule out alternative explanations.

What This Could Mean for Managing Your Own Cardiometabolic Risk

For a reader already worried about heart, kidney, or metabolic health, this study is not a reason to start taking a probiotic marketed for oral health or to assume better dental hygiene alone will lower cardiovascular risk, since the study did not test any intervention and cannot say whether changing oral bacteria would change outcomes. What it does suggest is that oral microbial diversity may be a useful marker worth researching further, alongside the things doctors already track, like blood pressure, blood sugar, and kidney function. The study's mediation analysis found that frailty, a 49-item index capturing accumulated deficits across physical, cognitive, and functional domains, statistically explained a meaningful share of the mortality association, between 15% and 37% depending on which diversity metric was used. That points toward general physiological resilience, rather than any single mechanism like inflammation, as one plausible link between the mouth and mortality risk, though the researchers stress this remains exploratory. Anyone with existing gum disease, diabetes, kidney disease, or heart disease may want to bring up oral health as part of a broader conversation with their doctor, without treating this study as evidence that fixing oral bacteria will fix cardiometabolic disease.

Limitations of the Cardiovascular-Kidney-Metabolic Microbiome Findings

The authors are explicit that this is an observational study, meaning it cannot establish that oral bacteria cause changes in CKM risk or mortality, only that the two are statistically linked. Oral microbiome composition was measured only once per person, at the start of the study, even though the mouth's bacterial population is known to shift over time, so a single snapshot may not reflect someone's typical exposure over years. The analysis also did not apply NHANES's official survey weights, which the researchers note limits how confidently the results can be generalized to the broader US population, and the 16S rRNA sequencing method used identifies bacteria only at a coarse, genus-level resolution rather than pinpointing exact species or strains responsible for the effect. Residual confounding from unmeasured factors, such as medication use or detailed oral hygiene habits, also cannot be ruled out.

What Comes Next for Oral Microbiome and Cardiometabolic Research

The study's authors call for prospective intervention studies, meaning trials that actually try to shift oral microbial diversity and then track cardiometabolic outcomes, to establish whether the relationship is causal. They also flag a need for research using repeated oral microbiome measurements over time and more advanced sequencing methods capable of identifying specific bacterial species or strains, rather than the genus-level view offered by 16S rRNA sequencing, to pin down exactly which microbes might be driving the association. No timeline for such studies was given in the paper.

Common Questions

Does this mean mouthwash or better brushing will lower my heart disease risk? No. The study measured naturally occurring bacterial diversity and did not test any oral hygiene intervention, so it cannot say whether changing your oral microbiome through brushing, mouthwash, or supplements would affect cardiovascular or mortality risk.

Is oral microbial diversity the same as gut microbiome diversity? No, they are related but distinct microbial communities. The study adjusted for periodontitis (gum disease) separately from diversity itself, and the researchers note that oral microbiome research generally lags behind gut microbiome research in scientific development.

Which bacterial diversity measure mattered most? Faith's phylogenetic diversity, which accounts for how evolutionarily distinct the bacterial species are, showed the strongest link to advanced CKM syndrome, while the Shannon-Weiner and Simpson indices, which weigh species evenness more heavily, showed the strongest links to cardiovascular death specifically.

Could frailty explain the whole effect? No. Frailty statistically accounted for 15% to 37% of the mortality association depending on the diversity metric, meaning most of the link remains unexplained by frailty alone.

References

1. Zunni Zhang, Huiying Ji, Yumei Xu, Yunxiao Song, Jie Chen (2026). Unveiling the link between oral microbial α-diversity, advanced cardiovascular-kidney-metabolic syndrome, and mortality. Journal of Oral Microbiology. https://doi.org/10.1080/20002297.2026.2717777
2. (1985). Planning for the Third National Health and Nutrition Examination Survey (NHANES III). JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/75.3.593-a